Objectives of the EPS Conference
- Showcase Pharmacy Leadership through highlighting the evolving role of pharmacists in regulatory, clinical, community, and academic settings.
- Advance Clinical and Public Health Pharmacy Practice.
- Empower Pharmacist-Led Research and Evidence-Based Practice.
- Strengthen Professional Development and Workforce Readiness.
- Foster Strategic Collaboration and Networking.
- Launch EPS Strategic Vision (2025–2030).
Our vision
We envision a future where innovation and collaboration are the cornerstones of transformative healthcare solutions. To position pharmacists as pivotal leaders in health care by 2030—driving excellence in clinical practice, public health, education, research, and policy through a united, forward-thinking, and empowered pharmaceutical community.
Our mission
To advance pharmacy practice and leadership in UAE by empowering pharmacists across all sectors through knowledge exchange, innovation, research, and strategic collaboration, ultimately enhancing healthcare outcomes and public health.
ACCREDITATIONS
Explore our conference agenda designed to empower pharmacists through insightful sessions, expert panels, and collaborative opportunities.
INTRODUCING OUR SCIENTIFIC COMMITTEE
-
Dr. Abdulla Al KindiPresident, Emirates Pharmacy Society -
Dr. Amal AlsereidiClinical Pharmacist, Dibba Hospital, EHS -
Dr. Amna AlmuainiCardiology Clinical Pharmacist, STMC Hospital — BPharm, MSc, BPS; Board Member, EPS -
Dr. Halima Salem Al DhanhaniHead of Pharmacy Dept., Fujairah Hospital – EHS; Cultural Chairperson, EPS -
Dr. Khuloud Bin RafeeaChair, EPS Conference Scientific Committee; Vice President, EPS; Director, Drugs & Medical Products, DoH – Abu Dhabi -
Dr. Raya ZayadeenCo-Chair, EPS Conference Scientific Committee; VP, M42 P&T — Global Patient Care (UAE & Bahrain) -
Dr. Amal AkourAssociate Professor of Pharmacotherapy, CMHS, United Arab Emirates University -
Dr. Rola KaakehCEO, Salus Vitae Group -
Prof. Samar MansourDean, German International University; ISPOR UAE Board — Scientific Committee Co-Head -
Dr. Rania El LababidiPGY2 Infectious Diseases Residency Program Director, Cleveland Clinic Abu Dhabi
